PCN77 COST EFFECTIVENESS ANALYSIS OF LENVATINIB FOR THE FIRST-LINE TREATMENT OF INDIVIDUALS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA
X. Li
◽
G. Wudong
◽
Y. Wang
2020 ◽
Vol 40
(12)
◽
pp. 743-745
2021 ◽
Vol 41
(5)
◽
pp. 1097-1104
Feng Wen
◽
Hanrui Zheng
◽
Pengfei Zhang
◽
Weiting Liao
◽
Kexun Zhou
◽
...
2015 ◽
Vol 18
(7)
◽
pp. A460
◽
J Vargas-Valencia
◽
J Garcia Perlaza
2017 ◽
Vol 20
(6)
◽
pp. 574-584
◽
Fernando Rivera
◽
Manuel Valladares
◽
Salvador Gea
◽
Noemí López-Martínez
2016 ◽
Vol 19
(3)
◽
pp. A153
2018 ◽
Vol 29
(8)
◽
pp. 1221-1221
Herbert H. Loong
◽
Carlos K. H. Wong
◽
Linda K. S. Leung
◽
S. C. Tan
◽
Jason Jen
◽
...
2019 ◽
Vol 94
◽
pp. 80-85
◽
Xudong Chen
◽
Weiting Liang
◽
Ning Wan
◽
Li Zhang
◽
Yunpeng Yang
◽
...
2015 ◽
Vol 18
(7)
◽
pp. A446
◽
T Piha
◽
D Barbosa
◽
L Fahham
1996 ◽
Vol 78
(11)
◽
pp. 2366-2373
◽
Andrea Messori
◽
Sabrina Trippoli
◽
Paola Becagli
◽
Enrico Tendi